Contact
Please use this form to send email to PR contact of this press release:
Kaleido Biosciences Announces Positive Interim Results of Controlled Study of KB109 in Patients with Mild-to-Moderate COVID-19
TO:
Please use this form to send email to PR contact of this press release:
Kaleido Biosciences Announces Positive Interim Results of Controlled Study of KB109 in Patients with Mild-to-Moderate COVID-19
TO: